SC-0062

N/A

Report date: 2025/05/12 15:59:03
NME

Base Information

Drug NameSC-0062
Drug Alias NameSC-0062WX-013
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type A antagonistsSignal transduction pathway modulators
TargetsEndothelin receptor type A
Therapy Area/IndicationsGlomerulonephritis, IGADiabetic NephropathiesKidney Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShijiazhuang Zhikang Hongren New Drug Development Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShijiazhuang Zhikang Hongren New Drug Development Co LtdWuxi BioCity
Inactive CompaniesN/A
Active IndicationsGlomerulonephritis, IGADiabetic NephropathiesKidney Diseases +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A